119 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
NVO Novo Nordisk A/S $45.65 $135.11B Downtrend
Article Searches
Top Diabetes Stocks to Buy Today https://www.fool.com/investing/2018/05/31/top-diabetes-stocks-to-buy-today.aspx?source=iedfolrf0000001 May 31, 2018 - More people than ever are being diagnosed with diabetes, and big advances in treatment could make these diabetes stocks savvy investments.
Stocks making the biggest moves premarket: DKS, TGT, CRM, HPQ, NVO, KORS & more https://www.cnbc.com/2018/05/30/stocks-making-the-biggest-moves-premarket-dks-tgt-crm-hpq-nvo-kors-more.html May 30, 2018 - Names on the move ahead of the open.
Novo Nordisk's Oral Ozempic Positive in Diabetes Study http://www.zacks.com/stock/news/305565/novo-nordisks-oral-ozempic-positive-in-diabetes-study?cid=CS-ZC-FT-305565 May 30, 2018 - Novo Nordisk's (NVO) oral formulation of Ozempic acts better in lowering blood sugar levels in adults with type II diabetes than Eli Lilly's Jardiance, in the second phase IIIa study, PIONEER 2.
How to Invest in Diabetes Stocks https://www.fool.com/investing/2018/05/25/how-to-invest-in-diabetes-stocks.aspx?source=iedfolrf0000001 May 25, 2018 - Here's everything you need to know about investing in the fast-growing diabetes market.
Top Research Reports for Walmart, AT&T & Novo Nordisk http://www.zacks.com/research-daily/162868/top-research-reports-for-walmart-att-novo-nordisk?cid=CS-ZC-FT-162868 May 18, 2018 - Top Research Reports for Walmart, AT&T & Novo Nordisk
Novo Nordisk Fights Payer Pressure With New Meds https://www.fool.com/investing/2018/05/07/novo-nordisk-fights-payer-pressure-with-new-meds.aspx?source=iedfolrf0000001 May 07, 2018 - Sales of older medications are on the decline, but newer medications helped the revenue line grow at constant exchange rates.
Novo Nordisk (NVO) Q1 2018 Earnings Conference Call Transcript https://www.fool.com/earnings/call-transcripts/2018/05/03/novo-nordisk-nvo-q1-2018-earnings-conference-call.aspx?source=iedfolrf0000001 May 03, 2018 - NVO earnings call for the period ending March 31, 2018.
Novo Nordisk A/S (NVO) Q1 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4168612-novo-nordisk-s-nvo-q1-2018-results-earnings-call-transcript?source=feed_sector_healthcare May 02, 2018 - Novo Nordisk A/S (NYSE:NVO)Q1 2018 Earnings CallMay 02, 2018 7:00 am ETExecutivesLars Fruergaard Jørgensen - Novo Nordisk A/SMads Krogsgaard Thomsen - Novo Nordisk A/SKarsten Munk Knudsen - Novo Nordi
Novo Nordisk (NVO) Beats Q1 Earnings Estimates, Sales Miss http://www.zacks.com/stock/news/301962/novo-nordisk-nvo-beats-q1-earnings-estimates-sales-miss?cid=CS-ZC-FT-301962 May 02, 2018 - Novo Nordisk's (NVO) first-quarter 2018 results beat earnings, but missed on revenue estimates.
This Small Biotech Is Building on a Surprising Success https://www.fool.com/investing/2018/04/24/this-small-biotech-is-building-on-a-surprising-suc.aspx?source=iedfolrf0000001 Apr 24, 2018 - Enanta Pharmaceuticals helped AbbVie score big last year. Now it's setting its sights even higher.

Pages: 123456...12

Page 1>